Mumbai, March 5 -- Granules Conusmer health is a wholly-owned subsidiary of Granules Pharmaceuticals, Inc and step-down subsidiary of the Granules India. It serves as Granules' front-end division for OTC products in the U.S., leveraging Granules India's manufacturing efficiencies, regulatory compliance, and integrated supply chain.

The FDA inspection was conducted at the company's packaging facility in Manassas, Virginia, from December 1 to 3, 2025. This marks the facility's second FDA inspection, following the March 2023 audit, which also concluded with zero observations.

Krishna Prasad Chigurupati, chairman and managing director of Granules India, said, "Granules Consumer Health plays a critical role in our global operations as a pack...